EPA:ORP - Euronext Paris - Matif - FR001400NLM4 - Common Stock - Currency: EUR
Taking everything into account, ORP scores 4 out of 10 in our fundamental rating. ORP was compared to 30 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of ORP while its profitability can be described as average. ORP is not overvalued while it is showing excellent growth. This is an interesting combination.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.74% | ||
ROE | 71.82% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | 26.07% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.3 | ||
Debt/FCF | N/A | ||
Altman-Z | 0.39 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.6 | ||
Quick Ratio | 0.6 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 1.2 | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
EPA:ORP (7/2/2024, 5:28:19 PM)
12.465
+0.15 (+1.24%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 1.2 | ||
Fwd PE | N/A | ||
P/S | 0.38 | ||
P/FCF | N/A | ||
P/OCF | 5.42 | ||
P/B | 1.05 | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.74% | ||
ROE | 71.82% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | 26.07% | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.3 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | 8.78% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.6 | ||
Quick Ratio | 0.6 | ||
Altman-Z | 0.39 |